2023 international evidence-based guideline pcos glp-1 receptor agonist Frontiers The PMOS Prescription Nobody Explains:

Most people find it okay, with only a few minor issues

Relax, unwind and feel like your best self again

There is no downtime at all and no side affects

Of the two main incretin hormones released with food ingestion, the actions of glucagon-like peptide-1 (GLP-1) have been exploited for therapeutic benefit

Risk factors for Korsakoffs syndrome include repetitive thiamine deficiency episodes and genetic predispositions, such as mutations in the transketolase enzyme that reduce its affinity for TPP (40, 42)

With multiple delivery options including oral, topical, and injectable formulations alongside high stability and a strong safety profile, BPC-157 shows significant therapeutic potential